Mr Ken Sullivan, Sales & Marketing - US Agent
Ken Sullivan is based at Boron Molecular’s sales office at Raleigh, NC, USA. He joined Boron Molecular in September 2004. He is a skilled and experienced sales professional with direct experience selling boronic chemicals to large and medium sized businesses. He is a graduate of North Carolina State University with a degree in Zoology. He is engaged by Boron Molecular via an agency agreement operating between Boron Molecular and an entity controlled by Mr Sullivan.
Dr Jacob Golding, General Manager
Dr Golding joined the Company as its Operations Manager in June 2007. Previous industry experience saw Jacob employed as a senior development chemist at SDI Australia Limited - a company primarily involved in the R&D, process development, manufacturing and marketing of specialist dental restorative materials. Dr Golding has also gained valuable experience in several other internationally respected institutions, including Monash University (School of Chemistry & the Green Chemistry Centre) and at CSIRO (Manufacturing and Infrastructure Technology). Dr Golding has a history of success in research, education, management and private industry roles. Jacob’s role at Boron has crossed over into process development and large scale production management and includes the management and implementation of all quality control systems though-out the company.
Dr Michael Nairn, Production and Product Development Manager
Dr Nairn obtained his PhD in organic chemistry from Massey University in New Zealand. After postdoctoral work at the University of Sydney looking at anti-cancer compounds, he was employed as a medicinal chemist at The Australian National University in a joint venture with GlaxoSmithkline pharmaceuticals. There he worked on a range of anti-bacterial enzyme inhibitors which involved active site modelling, bioassays, electrospray mass spectrometry and semi-preparative HPLC. In 2003 he joined the staff at Boron Molecular as a synthetic chemist, and since this time has been involved with the development of Boron Molecular's product range, process transfer and scale up of R&D procedures, custom synthesis and intermediate sourcing.